Formulation, characterization and cellular toxicity assessment of a novel bee-venom microsphere in prostate cancer treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Formulation, characterization and cellular toxicity assessment of a novel bee-venom microsphere in prostate cancer treatment ; volume:12 ; number:1 ; day:2 ; month:8 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (2.8.2022), 1-10, 12.2022
- Creator
-
El-Didamony, Samia E.
Amer, Reham I.
El-Osaily, Ghada H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17391-w
- URN
-
urn:nbn:de:101:1-2022101219132788700902
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.01.2025, 12:41 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El-Didamony, Samia E.
- Amer, Reham I.
- El-Osaily, Ghada H.
- SpringerLink (Online service)
Other Objects (12)
Acute Dermal Toxicity Study of Bee Venom (Apis mellifera L.) in Rats
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Immune thrombocytopenia after bee venom therapy: a case report
Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
Bee core venom genes predominantly originated before aculeate stingers evolved
Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
Bee venom as an alternative for antibiotics against Staphylococcus aureus infections
Prevalent bee venom genes evolved before the aculeate stinger and eusociality
Assessment of bee venom therapy in animal model of statin-induced myopathy
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art
Improved Therapeutic Profiles of PLA2-Free Bee Venom Prepared by Ultrafiltration Method
Acute Dermal Toxicity Study of Bee Venom (Apis mellifera L.) in Rats
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Immune thrombocytopenia after bee venom therapy: a case report
Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
Bee core venom genes predominantly originated before aculeate stingers evolved
Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
Bee venom as an alternative for antibiotics against Staphylococcus aureus infections
Prevalent bee venom genes evolved before the aculeate stinger and eusociality
Assessment of bee venom therapy in animal model of statin-induced myopathy
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art
Improved Therapeutic Profiles of PLA2-Free Bee Venom Prepared by Ultrafiltration Method
Acute Dermal Toxicity Study of Bee Venom (Apis mellifera L.) in Rats
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Immune thrombocytopenia after bee venom therapy: a case report
Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
Bee core venom genes predominantly originated before aculeate stingers evolved
Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom
Bee venom as an alternative for antibiotics against Staphylococcus aureus infections
Prevalent bee venom genes evolved before the aculeate stinger and eusociality
Assessment of bee venom therapy in animal model of statin-induced myopathy
Risk factors in bee and Vespula venom allergy: state of the art
Risk factors in bee and Vespula venom allergy: state of the art